In 2023, 1.4 Percent of U.S. Children Ever Experienced Post-COVID Condition

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 12, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Feb. 12, 2025 -- Post-COVID condition (PCC) continues to affect children, and 80 percent of those currently experiencing PCC have activity limitation, according to a research letter published online Feb. 3 in JAMA Pediatrics.

Nicole D. Ford, Ph.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues used data from the 2023 National Health Interview Survey to estimate the prevalence of ever and current PCC in U.S. children aged 0 to 17 years and activity limitations among children currently experiencing PCC.

The analytic sample included 7,585 unweighted and 71,027,000 weighted children. The researchers found that about 1.4 percent of children had ever experienced PCC and an estimated 0.4 percent were currently experiencing PCC at the time of interview in 2023. The prevalence of ever and currently experiencing PCC increased with older age (2.3 and 0.8 percent at age 12 to 17 years). With decreasing family income, the prevalence of ever experiencing PCC increased (<100 percent income-to-poverty ratio, 2.6 percent). Compared with non-Hispanic Black children and children from another or multiple races, the prevalence of ever experiencing PCC was higher among Hispanic and non-Hispanic White children. There was variation in the prevalence of ever experiencing PCC by health insurance. Eighty percent of children currently experiencing PCC had any activity limitation compared with the period before they had COVID-19.

"The large proportion of children experiencing PCC with any activity limitation highlights the need to examine the severity of activity limitation, functional outcomes, and days lost from school," the authors write.

Abstract/Full Text (subscription or payment may be required)

Stay up to date on the latest in health— click here to subscribe to our weekly newsletter!

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-02-13 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords